BridgeMD
New treatment option for Aggression
Official title Virtual Reality Intervention (VR-GINSO) for Reducing Aggression in Young Offenders
ClinicalTrials.gov ID: NCT07484919
What this study is testing
- What it's testing
- The goal of this clinical trial is to see if a specific intervention program that uses virtual reality (VR) helps young people reduce aggressive behavior more than the same program without VR or their usual treatment. The study will also look at how the program affects anger, impulsivity, emotional control, and how participants understand and handle conflicts with others.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 18
You may be able to join if
- 12-18 years old at the moment of recruitment and allocation.
- Minimum facility stay of 6 months since the begining of the study.
- Documented records of recent aggresive behavior.
You likely can't join if
- Neurological disorder, brain injury, or psyquiatric pathology that affects cognitive functions or advises against use of virtual reality.
- Not being fluent in Spanish.
The study team makes the final eligibility decision.
Where it's taking place
- Pozuelo de Alarcón, Cominity of Madrid, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pozuelo de Alarcón, Cominity of Madrid, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.